[Sponsored] At INVEST Digital Health 2025, David Snow, Executive Director of Pegasus Park, discussed building a life science innovation hub and why life science startups at the North Texas campus are more likely to survive, scale, and exit. The post The Burgeoning Life Science Ecosystem of North Texas, Anchored by Pegasus Park appeared first on…
Truth is, there are hugely positive tailwinds at our back. But the way we’ve been thinking about the problem is holding us back from solving it. Here’s why. The post Dear Mr. Buffett: Healthcare Isn’t Hopeless appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Gilead Sciences is acquiring Ouro Medicines, a startup developing T cell engagers for a range of autoimmune diseases. Separately, Gilead is negotiating a deal with Galapagos to share in the development and potential commercialization of the Ouro drug. The post Gilead Sciences Gains an Opportunity for Immune System Reset With $1.7B Ouro Acquisition appeared first…
This analysis examines PEPFAR spending and HIV viral suppression rates in 22 countries from 2018–2023 to help identify which investments most effectively drive HIV outcomes and inform future directions.
When pediatrician Eric Ball opened a refrigerator full of childhood vaccines, all the expected shots were there — DTaP, polio, pneumococcal vaccine — except one. “This is where we usually store our covid vaccines, but we don’t have any right now because they all expired at the end of last year and we had to…
Kaiser Permanente is showing no signs of slowing down when it comes to its Risant Health experiment. The organization is currently on the prowl for more acquisition targets, Kaiser CEO Greg Adams said at HLTH. The post Why Greg Adams Believes Risant Health Will Be Successful In Its Mission to Scale VBC Across the Country…
AI-powered platforms can collect data sets from disparate sources and check them for quality, duplication, relevance, and more. These platforms can then create even more extensive, understandable findings to help healthcare professionals make decisions. The post To Help Achieve Life-Saving Discoveries, AI Must Access ‘Underutilized, Undervalued’ Findings appeared first on MedCity News.
Chemical food additive and pesticide concerns associated with the Make America Health Again (MAHA) movement are shared broadly across the public. But when it comes to voters, health care costs are a higher priority and bigger motivator, even among MAHA supporters, a new KFF Health Tracking Poll finds.
BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential to match the efficacy of the blockbuster Takeda Pharmaceutical drug that currently dominates the market, but with less burdensome dosing that could encourage HAE patients to switch. The post BioCryst’s…